Skip to main content
. 2024 Feb 24;15(8):2110–2122. doi: 10.7150/jca.93373

Table 4.

Subgroup analysis of the effect of FASTKD2 on prognosis of patients with lung adenocarcinoma

graphic file with name jcav15p2110g006.jpg